MS4A6A and glioblastoma: In our study, based on multi‐omics and multiple machine learning approaches, we not only found that MS4A6 is a key gene for macrophages in GBM, but also found that it accurately predicts poor prognosis in gliomas, correlating with the biologically malignant characteristics of numerous tumours.